Skip to main content
. 2015 Mar 26;10:677–687. doi: 10.2147/COPD.S76520

Figure 6.

Figure 6

Percent change from baseline in severity and impact of early morning symptoms at Week 12 in the ACCORD COPD I study.

Notes: P=0.0009, P=0.0002.

Abbreviations: ACCORD, AClidinium in Chronic Obstructive Respiratory Disease I; BID, twice daily.